Quoin Pharmaceuticals, Ltd. (QNRX) NASDAQ

7.41

+0.04(+0.54%)

Updated at September 10 04:00PM

Currency In USD

Quoin Pharmaceuticals, Ltd.

Address

42127 Pleasant Forest Court

Ashburn, VA 20148-7349

United States of America

Phone

703 980 4182

Sector

Healthcare

Industry

Biotechnology

Employees

3

First IPO Date

August 01, 2016

Key Executives

NameTitlePayYear Born
Dr. Michael Myers Ph.D.Co-Founder, Chief Executive Officer & Chairman722,5501962
Mr. Gordon Bruce Dunn J.D.Chief Financial Officer433,6201964
Ms. Denise CarterCo-Founder, Chief Operating Officer & Director593,6051969

Description

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.